Mineralys Therapeutics, Common Stock Price History

MLYS Stock   16.78  0.61  3.77%   
If you're considering investing in Mineralys Stock, it is important to understand the factors that can impact its price. As of today, the current price of Mineralys Therapeutics, stands at 16.78, as last reported on the 26th of March, with the highest price reaching 17.08 and the lowest price hitting 16.28 during the day. Mineralys Therapeutics, appears to be somewhat reliable, given 3 months investment horizon. Mineralys Therapeutics, has Sharpe Ratio of 0.0923, which conveys that the firm had a 0.0923 % return per unit of risk over the last 3 months. By analyzing Mineralys Therapeutics,'s technical indicators, you can evaluate if the expected return of 0.68% is justified by implied risk. Please exercise Mineralys Therapeutics,'s Mean Deviation of 4.36, downside deviation of 4.85, and Risk Adjusted Performance of 0.0903 to check out if our risk estimates are consistent with your expectations.
  
At this time, Mineralys Therapeutics,'s Total Stockholder Equity is comparatively stable compared to the past year. Other Stockholder Equity is likely to gain to about 518.5 M in 2025, whereas Liabilities And Stockholders Equity is likely to drop slightly above 128.6 M in 2025. . At this time, Mineralys Therapeutics,'s Price Book Value Ratio is comparatively stable compared to the past year. Price To Book Ratio is likely to gain to 3.28 in 2025, whereas Price Earnings To Growth Ratio is likely to drop (0.04) in 2025. Mineralys Stock price history is provided at the adjusted basis, taking into account all of the recent filings.

Sharpe Ratio = 0.0923

Best PortfolioBest Equity
Good Returns
Average Returns
Small ReturnsMLYS
CashSmall RiskAverage RiskHigh RiskHuge Risk
Negative Returns

Estimated Market Risk

 7.38
  actual daily
65
65% of assets are less volatile

Expected Return

 0.68
  actual daily
13
87% of assets have higher returns

Risk-Adjusted Return

 0.09
  actual daily
7
93% of assets perform better
Based on monthly moving average Mineralys Therapeutics, is performing at about 7% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Mineralys Therapeutics, by adding it to a well-diversified portfolio.
Price Book
5.3094
Book Value
3.839
Enterprise Value
817.3 M
Enterprise Value Ebitda
(7.41)
Shares Float
25.2 M

Mineralys Therapeutics, Stock Price History Chart

There are several ways to analyze Mineralys Stock price data. The simplest method is using a basic Mineralys candlestick price chart, which shows Mineralys Therapeutics, price history and the buying and selling dynamics of a specified period. Many traders also use subjective judgment to their trading calls, avoiding the need to trade based on technical analysis.
Highest PriceMarch 21, 202516.87
Lowest PriceFebruary 25, 20258.76

Mineralys Therapeutics, March 26, 2025 Stock Price Synopsis

Various analyses of Mineralys Therapeutics,'s daily price changes, such as its Balance Of Power or Price Action, are crucial when deciding whether to buy, hold, or sell Mineralys Stock. It can be used to describe the percentage change in the price of Mineralys Therapeutics, from one trading day to the next and could be a valuable metric for traders and investors to gauge the volatility and momentum of Mineralys Stock.
Mineralys Therapeutics, Price Action Indicator 0.41 
Mineralys Therapeutics, Price Daily Balance Of Power 0.76 
Mineralys Therapeutics, Price Rate Of Daily Change 1.04 
Mineralys Therapeutics, Accumulation Distribution 62,777 

Mineralys Therapeutics, March 26, 2025 Stock Price Analysis

When benchmark price declines in a down market, there may be an uptick in Mineralys Stock price where buyers come in believing the asset is cheap or selling overdone. The opposite is true when the market is bullish. You can use Mineralys Therapeutics, intraday prices and daily technical indicators to check the level of noise trading in Mineralys Stock and then apply it to test your longer-term investment strategies against Mineralys.

Mineralys Stock Price History Data

The price series of Mineralys Therapeutics, for the period between Thu, Dec 26, 2024 and Wed, Mar 26, 2025 has a statistical range of 8.11 with a coefficient of variation of 19.56. The daily prices for the period are spread out with arithmetic mean of 11.39. The median price for the last 90 days is 10.27.
OpenHighLowCloseVolume
03/25/2025 16.71  17.08  16.28  16.78  1,340,296 
03/24/2025 17.08  17.35  16.15  16.17  1,075,975 
03/21/2025 16.60  17.26  16.56  16.87  832,135 
03/20/2025 16.43  17.29  16.32  16.73  881,412 
03/19/2025 15.47  18.38  15.23  16.75  2,285,000 
03/18/2025 14.46  15.50  14.31  15.43  1,718,462 
03/17/2025 14.28  14.46  13.80  14.22  636,362 
03/14/2025 13.87  14.40  13.53  14.25  1,294,762 
03/13/2025 13.03  13.95  12.77  13.50  1,389,226 
03/12/2025 12.59  13.57  12.55  13.11  5,518,890 
03/11/2025 15.30  15.98  13.41  14.30  2,751,095 
03/10/2025 14.13  18.29  13.50  14.96  15,216,999 
03/07/2025 10.57  10.77  10.19  10.52  644,585 
03/06/2025 9.86  10.82  9.69  10.54  321,065 
03/05/2025 10.00  10.33  9.80  10.01  189,701 
03/04/2025 8.85  10.00  8.79  9.92  290,882 
03/03/2025 9.17  9.44  8.69  8.94  301,367 
02/28/2025 10.01  10.08  9.00  9.14  448,624 
02/27/2025 9.77  10.24  9.68  9.96  286,427 
02/26/2025 8.77  9.88  8.76  9.68  315,475 
02/25/2025 9.28  9.29  8.24  8.76  996,100 
02/24/2025 9.54  9.58  9.22  9.25  263,511 
02/21/2025 9.69  9.85  9.37  9.56  335,438 
02/20/2025 9.33  9.67  9.14  9.53  300,501 
02/19/2025 9.38  9.50  8.98  9.32  434,241 
02/18/2025 10.19  10.75  9.50  9.60  583,150 
02/14/2025 10.01  10.64  10.01  10.24  245,931 
02/13/2025 10.15  10.67  10.15  10.20  373,671 
02/12/2025 10.61  11.09  9.65  10.63  395,636 
02/11/2025 9.34  9.70  9.02  9.66  307,912 
02/10/2025 9.81  10.18  9.44  9.51  233,912 
02/07/2025 10.02  10.85  9.72  9.81  338,332 
02/06/2025 10.21  10.38  9.99  10.05  225,898 
02/05/2025 10.34  10.90  10.17  10.26  227,300 
02/04/2025 9.86  10.24  9.81  10.21  275,366 
02/03/2025 10.03  10.46  9.82  9.93  280,747 
01/31/2025 10.27  10.47  10.07  10.30  193,749 
01/30/2025 10.47  10.78  10.22  10.27  130,667 
01/29/2025 9.83  10.79  9.57  10.36  460,605 
01/28/2025 10.01  10.08  9.76  9.86  144,958 
01/27/2025 9.87  10.32  9.57  10.00  143,885 
01/24/2025 10.26  10.56  9.89  9.97  206,807 
01/23/2025 10.16  10.71  9.91  10.26  204,332 
01/22/2025 9.80  10.43  9.74  10.19  249,072 
01/21/2025 9.33  9.82  9.27  9.77  329,484 
01/17/2025 9.58  9.87  9.18  9.24  234,826 
01/16/2025 9.80  9.90  9.37  9.50  251,290 
01/15/2025 9.31  9.97  9.24  9.83  246,166 
01/14/2025 9.36  9.39  8.90  9.12  281,536 
01/13/2025 9.63  9.76  8.60  9.36  388,973 
01/10/2025 10.77  10.77  9.31  9.87  435,348 
01/08/2025 12.81  13.00  10.60  11.20  602,510 
01/07/2025 12.99  13.37  12.83  12.98  268,809 
01/06/2025 12.79  13.09  12.73  13.05  132,120 
01/03/2025 12.33  12.99  12.16  12.75  158,198 
01/02/2025 12.33  12.66  12.00  12.25  188,898 
12/31/2024 12.55  12.69  12.04  12.31  61,457 
12/30/2024 12.76  12.91  12.03  12.52  197,696 
12/27/2024 12.81  13.43  12.50  12.82  158,603 
12/26/2024 12.59  13.00  12.05  12.87  280,443 
12/24/2024 12.31  12.81  11.99  12.80  218,530 

About Mineralys Therapeutics, Stock history

Mineralys Therapeutics, investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Mineralys is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Mineralys Therapeutics, will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Mineralys Therapeutics, stock prices may prove useful in developing a viable investing in Mineralys Therapeutics,
Last ReportedProjected for Next Year
Common Stock Shares Outstanding48.5 M44.8 M
Net Loss-26.8 M-28.2 M

Mineralys Therapeutics, Quarterly Net Working Capital

190.71 Million

Mineralys Therapeutics, Stock Technical Analysis

Mineralys Therapeutics, technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
A focus of Mineralys Therapeutics, technical analysis is to determine if market prices reflect all relevant information impacting that market. A technical analyst looks at the history of Mineralys Therapeutics, trading pattern rather than external drivers such as economic, fundamental, or social events. It is believed that price action tends to repeat itself due to investors' collective, patterned behavior. Hence technical analysis focuses on identifiable price trends and conditions. More Info...

Did you try this?

Run Commodity Channel Now

   

Commodity Channel

Use Commodity Channel Index to analyze current equity momentum
All  Next Launch Module

Mineralys Therapeutics, Technical and Predictive Indicators

Predictive indicators are helping investors to find signals for Mineralys Therapeutics,'s price direction in advance. Along with the technical and fundamental analysis of Mineralys Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Mineralys to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.

Additional Tools for Mineralys Stock Analysis

When running Mineralys Therapeutics,'s price analysis, check to measure Mineralys Therapeutics,'s market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Mineralys Therapeutics, is operating at the current time. Most of Mineralys Therapeutics,'s value examination focuses on studying past and present price action to predict the probability of Mineralys Therapeutics,'s future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Mineralys Therapeutics,'s price. Additionally, you may evaluate how the addition of Mineralys Therapeutics, to your portfolios can decrease your overall portfolio volatility.